25
Participants
Start Date
December 31, 2005
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
bevacizumab and radiation (IMRT)
bevacizumab 10 mg/kg IV once every two weeks on days 1 and 15 of every cycle (cycle defined as 28 days). If the tumor volume remains \< 40 cc, the patient will undergo stereotactic radiotherapy with IMRT (30Gy) beginning anywhere from day 7-10 of cycle 2 (5 doses of 6 Gy over 2 and a half weeks)
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack
Collaborators (1)
Weill Medical College of Cornell University
OTHER
Genentech, Inc.
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER